Website: Aduro Biotech
Business Area(s):
Description: Aduro’s three proprietary technology platforms (Live, Attenuated Double-Deleted Listeria (LADD), STING Pathway Activators, and B-select monoclonal antibodies) have the potential to transform the current immunotherapy and cancer care landscape.